Vignesh Rajah is CMO & VP at Y-mAbs Therapeutics, Inc. (YMAB). They have made 4 open-market trades across 1 company since 2020, most recently 2024-03-05.
CIK 0001815042
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $193K since 2020, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| YMAB | 33,889 | $292K |
Shares reported on the most recent Form 4, priced at the 2024-03-07 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.